Pathogenic sensor’s surprising capabilities revealed
Rice synthetic biologists have uncovered new capabilities of a genetically encoded sensor that allows salmonella, E. coli and other pathogens to sicken millions of people each year.
HIV ‘drug factory’ implant promises once-a-year therapy
A Rice University lab is developing encapsulated cellular “drug factories” to treat patients with HIV through a once-a-year implant.
Brain cancer research draws support
Bioengineer Kevin McHugh wins a Distinguished Scientist Award for brain cancer research from The Sontag Foundation.
Rice funds new research collaborations with Houston Methodist
Rice and Houston Methodist have awarded seed grants for research in robotics, imaging, cardiovascular bioengineering, and psychological and behavioral health.
Rice facility is ‘one-stop shop’ for customizing DNA to fight cancer
Rice bioengineers, synthetic biologists and cancer researchers celebrated the opening of Rice’s first CPRIT Core Facility, the Genetic Design and Engineering Center, or GDEC, Nov. 10 at the BRC.
Rice, Baylor to study how screen use affects young children
Rice engineers and Baylor College of Medicine researchers are studying how screen use affects young children.
Engineers explore the source of dreams and thoughts
Rice neuroengineers created a 3D electrode array that can identify up to 1 million potential synapses in the brain.
Construction begins on Center for Human Performance
Leaders from Rice and Houston Methodist gathered at Tudor Fieldhouse Aug. 19 to celebrate the start of construction on the Houston Methodist-Rice University Center for Human Performance.
‘Drug factory’ implants eliminate mesothelioma tumors in mice
Rice and Baylor researchers have used Rice’s “drug factory” implants to eradicate advanced-stage mesothelioma tumors in mice.
Rice, Baylor developing implants to heal heart attack injuries
Rice and Baylor College of Medicine are creating tiny implants that can heal damage from heart attacks.
Rice lab’s ‘drug factory’ implants cleared for human trials
Federal regulators have approved the first human clinical trial of cancer-killing “drug factory” implants created by Rice bioengineers.
Ken Kennedy Institute will host AI in Health Conference Nov. 7-9
Rice's Ken Kennedy Institute is organizing and hosting the AI in Health Conference Nov. 7-9 at the BioScience Research Collaborative.
Researchers discover new leukemia-killing compounds
Researchers from Rice and MD Anderson Cancer Center have discovered potential new drugs for treating leukemia.
Rep. Dan Crenshaw hosts health care summit
Neuroengineer Jacob Robinson discussed research at U.S. Rep. Dan Crenshaw’s fourth annual health care summit at Rice.
Rice trains postdocs for nano-cancer future
The National Institutes of Health extend a grant to help future medical professionals understand nanotechnology-enabled tools to treat cancer.